Annual Cash & Cash Equivalents
$311.66 M
+$67.88 M+27.84%
December 31, 2023
Summary
- As of February 7, 2025, HRMY annual cash & cash equivalents is $311.66 million, with the most recent change of +$67.88 million (+27.84%) on December 31, 2023.
- During the last 3 years, HRMY annual cash & cash equivalents has risen by +$83.03 million (+36.32%).
- HRMY annual cash & cash equivalents is now at all-time high.
Performance
HRMY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$387.37 M
+$70.07 M+22.08%
September 30, 2024
Summary
- As of February 7, 2025, HRMY quarterly cash and cash equivalents is $387.37 million, with the most recent change of +$70.07 million (+22.08%) on September 30, 2024.
- Over the past year, HRMY quarterly cash and cash equivalents has increased by +$75.71 million (+24.29%).
- HRMY quarterly cash and cash equivalents is now at all-time high.
Performance
HRMY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HRMY Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.8% | +24.3% |
| 3 y3 years | +36.3% | +104.2% |
| 5 y5 years | +273.1% | - |
HRMY Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.0% | at high | +72.5% |
| 5 y | 5-year | at high | +1174.3% | at high | +1483.9% |
| alltime | all time | at high | +1174.3% | at high | +1483.9% |
Harmony Biosciences Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $387.37 M(+22.1%) |
| Jun 2024 | - | $317.30 M(-4.7%) |
| Mar 2024 | - | $332.98 M(+6.8%) |
| Dec 2023 | $311.66 M(+27.8%) | $311.66 M(-4.0%) |
| Sep 2023 | - | $324.60 M(+2.3%) |
| Jun 2023 | - | $317.42 M(+10.2%) |
| Mar 2023 | - | $287.96 M(+18.1%) |
| Dec 2022 | $243.78 M | $243.78 M(-6.7%) |
| Sep 2022 | - | $261.34 M(+10.5%) |
| Jun 2022 | - | $236.53 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $224.50 M(-4.2%) |
| Dec 2021 | $234.31 M(+2.5%) | $234.31 M(+23.5%) |
| Sep 2021 | - | $189.70 M(+18.8%) |
| Jun 2021 | - | $159.69 M(+13.1%) |
| Mar 2021 | - | $141.17 M(-38.3%) |
| Dec 2020 | $228.63 M(+834.8%) | $228.63 M(+3.1%) |
| Sep 2020 | - | $221.74 M(+190.7%) |
| Jun 2020 | - | $76.28 M(+6.7%) |
| Mar 2020 | - | $71.52 M(+192.4%) |
| Dec 2019 | $24.46 M(-70.7%) | $24.46 M |
| Dec 2018 | $83.52 M | - |
FAQ
- What is Harmony Biosciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual cash & cash equivalents year-on-year change?
- What is Harmony Biosciences Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly cash and cash equivalents year-on-year change?
What is Harmony Biosciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of HRMY is $311.66 M
What is the all time high annual cash & cash equivalents for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual cash & cash equivalents is $311.66 M
What is Harmony Biosciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, HRMY annual cash & cash equivalents has changed by +$67.88 M (+27.84%)
What is Harmony Biosciences Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HRMY is $387.37 M
What is the all time high quarterly cash and cash equivalents for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly cash and cash equivalents is $387.37 M
What is Harmony Biosciences Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, HRMY quarterly cash and cash equivalents has changed by +$75.71 M (+24.29%)